Zobrazeno 1 - 10
of 843
pro vyhledávání: '"YUTAKA SEINO"'
Autor:
Yuichiro Yamada, Daisuke Yabe, Kenichiro Shide, Atsushi Suzuki, Yasuo Terauchi, Yasunori Sato, Nobuyuki Shihara, Yutaka Seino
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 11, Pp 1585-1595 (2024)
ABSTRACT Aims/Introduction Sodium–glucose cotransporter 2 (SGLT2) inhibitors effectively and safely reduce fasting and postprandial hyperglycemia while promoting weight loss. However, their unique mechanism of action contributes to concerns regardi
Externí odkaz:
https://doaj.org/article/5c833119f5fa4657b1fea4470c388a25
Autor:
Yutaka Seino, Daisuke Yabe, Kazuhiro Tsumura, Chien‐Ning Huang, So Hun Kim, Weiping Jia, Altaisaikhan Khasag, Takashi Kadowaki
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 11, Pp 1533-1536 (2024)
Externí odkaz:
https://doaj.org/article/e2b6e1553d8745acb3292229a86c0b5b
Publikováno v:
JA Clinical Reports, Vol 10, Iss 1, Pp 1-5 (2024)
Externí odkaz:
https://doaj.org/article/ec765ab16b33450fbacdcd3f2b9c655d
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 1, Pp 63-66 (2024)
Sodium‐glucose cotransporter 2 inhibitors (SGLT2is) have been shown in cardiovascular outcome trials to reduce the risk of heart failure and major adverse cardiovascular as well as renal events in individuals with type 2 diabetes. Moreover, clinica
Externí odkaz:
https://doaj.org/article/4898f5f1e591483ca410335e04a7a427
Autor:
Yuya Takahashi, Hiroki Fujita, Yusuke Seino, Satoko Hattori, Shihomi Hidaka, Tsuyoshi Miyakawa, Atsushi Suzuki, Hironori Waki, Daisuke Yabe, Yutaka Seino, Yuichiro Yamada
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 6, Pp 2703-2718 (2023)
Abstract Background Intramuscular adipose tissue (IMAT) formation derived from muscle fibro‐adipogenic progenitors (FAPs) has been recognized as a pathological feature of sarcopenia. This study aimed to explore whether genetic and pharmacological g
Externí odkaz:
https://doaj.org/article/7b9f6304881048c88a12d2cf1871a207
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 8, Pp 933-935 (2023)
Externí odkaz:
https://doaj.org/article/068988c1ea014529987ef67ccd985778
Autor:
Dae Jung Kim, Wayne H‐H Sheu, Wook‐Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia‐Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz‐Luyet, Moe H Kyaw, Yutaka Seino, EMPRISE East Asia Study Group
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 3, Pp 417-428 (2023)
Abstract Aims/Introduction The EMPA‐REG OUTCOME® trial demonstrated benefits of empagliflozin, a sodium‐glucose cotransporter‐2 inhibitor (SGLT2i), on cardiovascular, renal outcomes and all‐cause mortality in patients with type 2 diabetes an
Externí odkaz:
https://doaj.org/article/4fadce44738c43919f7eaceb3654a8a9
Autor:
Sodai Kubota, Takuya Haraguchi, Hitoshi Kuwata, Yusuke Seino, Kenta Murotani, Takumi Tajima, Gen Terashima, Makiko Kaneko, Yoshihiro Takahashi, Ken Takao, Takehiro Kato, Kenichiro Shide, Saeko Imai, Atsushi Suzuki, Yasuo Terauchi, Yuichiro Yamada, Yutaka Seino, Daisuke Yabe
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 1, Pp 67-74 (2023)
ABSTRACT Aims/Introduction This study was designed and carried out to investigate the association of dipeptidyl peptidase‐4 inhibitor (DPP‐4i) use with pancreatic cancer (PC) in individuals with diabetes in Japan. Materials and Methods The JMDC C
Externí odkaz:
https://doaj.org/article/8fd79467e1a14780b953b0a7c7b9434d
Autor:
Nagaaki Tanaka, Yoshiyuki Hamamoto, Yuri Kurotobi, Yuji Yamazaki, Susumu Nakatani, Miho Matsubara, Takuya Haraguchi, Yuko Yamaguchi, Kiyohiro Izumi, Yuki Fujita, Hitoshi Kuwata, Takanori Hyo, Masaki Yanase, Masahiro Matsuda, Shinji Negoro, Hiroko Higashiyama, Yuichiro Yamada, Takeshi Kurose, Yutaka Seino
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 12, Pp 2081-2090 (2022)
Abstract Aims/Introduction The aim of this study was to develop a scale to evaluate disease stigma in patients with lifestyle‐related chronic non‐communicable diseases (LCNCDs), which we named the Kanden Institute Stigma Scale (KISS), and to cons
Externí odkaz:
https://doaj.org/article/30cab249e80249f8abafc1c7784394c6
Autor:
Yutaka Seino, Hideaki Miyoshi, Heidrun Bosch Traberg, T V S Divyalasya, Keiji Nishijima, Yasuo Terauchi
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 8, Pp 1321-1329 (2022)
ABSTRACT Aims/Introduction The present trial compared the efficacy and safety of once‐daily liraglutide 1.8 mg with liraglutide 0.9 mg in Japanese patients with type 2 diabetes to assess the incremental effects of liraglutide 1.8 mg in those who ex
Externí odkaz:
https://doaj.org/article/1fc252900df9478ab8966830b33cfd82